ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium
L. Karimi (Rotterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), M. Engelkes (Rotterdam, Netherlands), N. Hernandez-Pacheco (Santa Cruz de Tenerife, Spain), N. Farzan (Amsterdam, Netherlands), P. Soares (Brighton, United Kingdom), B. Francis (Liverpool, United Kingdom), M. Pino-Yanes (Santa Cruz de Tenerife, Spain), C. Eng (San Francisco, United States of America), S. Mukhopadhyay (Brighton, United Kingdom), M. Schieck (Regensburg, Germany), M. Kabesch (Regensburg, Germany), E. Burchard (San Francisco, United States of America), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), H. Janssens (Rotterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands)
Source: International Congress 2019 – Genes and environment
Session: Genes and environment
Session type: Poster Discussion
Number: 5388
Disease area: Airway diseases, Paediatric lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Karimi (Rotterdam, Netherlands), S. Vijverberg (Amsterdam, Netherlands), M. Engelkes (Rotterdam, Netherlands), N. Hernandez-Pacheco (Santa Cruz de Tenerife, Spain), N. Farzan (Amsterdam, Netherlands), P. Soares (Brighton, United Kingdom), B. Francis (Liverpool, United Kingdom), M. Pino-Yanes (Santa Cruz de Tenerife, Spain), C. Eng (San Francisco, United States of America), S. Mukhopadhyay (Brighton, United Kingdom), M. Schieck (Regensburg, Germany), M. Kabesch (Regensburg, Germany), E. Burchard (San Francisco, United States of America), C. Palmer (Dundee, United Kingdom), S. Turner (Aberdeen, United Kingdom), H. Janssens (Rotterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), K. Verhamme (Rotterdam, Netherlands). ADRB2 haplotypes and risk of exacerbations in asthmatic children and young adults treated with long-acting ß2-agonists: A meta-analysis in the PiCA consortium. 5388
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Genome-wide association study of asthma exacerbations in European children treated with inhaled corticosteroids Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
LSC 2013 abstract - ST13 and ORMDL3 polymorphisms affect the risk of exacerbations in steroid-treated asthmatic children and young adults Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
A genome-wide association study of severe asthma exacerbations in Latino children and adolescents Source: Eur Respir J, 57 (4) 2002693; 10.1183/13993003.02693-2020 Year: 2021
Determinants of incident asthma-COPD overlap compared to asthma and COPD alone: A prospective study of 55,110 middle-aged adults Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics Year: 2017
Twelve-year asthma incidence in asymptomatic bronchial responsiveness in adults and children from the EGEA study Source: Annual Congress 2007 - Risk factors for prevalence and incidence of asthma Year: 2007
Genome-wide association study of asthma symptoms despite inhaled corticosteroids use in Dutch children. Source: International Congress 2017 – Paediatric asthma: treatment modalities and behavioural issues Year: 2017
Rates of asthma exacerbations are not affected by beta2 -adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 708s Year: 2005
A polymorphism in DNASE1L3 is associated with severe asthma exacerbations in two-high risk populations for asthma Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
Genome-wide association study of inhaled corticosteroid response in African-admixed children with asthma. Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Efficacy of montelukast in Indian patients having chronic persistent asthma Source: Eur Respir J 2003; 22: Suppl. 45, 372s Year: 2003
Risk factors for severe bronchial asthma in young adults with childhood-onset asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2 Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Comparing asthma phenotypes in adults and children: a cohort of two years Source: Annual Congress 2007 - Risk factors for childhood asthma: cohort studies Year: 2007
Nickel allergy is associated with wheezing and asthma in a cohort of young German adults: results from the SOLAR study Source: ERJ Open Res, 6 (1) 00178-2019; 10.1183/23120541.00178-2019 Year: 2020
Association between genetic polymorphisms of the β2-AR and response to salbutamol in patients with atopic bronchial asthma of Kyrgyz nationality Source: Eur Respir J 2006; 28: Suppl. 50, 236s Year: 2006
How many young adults are at risk of COPD? Source: Eur Respir J 2002; 20: Suppl. 38, 124s Year: 2002
Characterization of asthma exacerbations by Arg16Gly genotype in subjects with asthma receiving salmeterol alone or with fluticasone propionate Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008
ADRB2 polymorphisms and risk of COPD exacerbations: the Rotterdam Study Source: International Congress 2019 – Genes and environment Year: 2019
Is asthma different in asthmatic siblings compared to asthmatics in general population? Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004
Long-acting beta2-agonists in adult asthma and the pattern of risk of death and severe asthma outcomes: a study using the GPRD Source: Eur Respir J 2010; 36: 494-502 Year: 2010